1. Home
  2. HGTY vs DRTS Comparison

HGTY vs DRTS Comparison

Compare HGTY & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hagerty Inc.

HGTY

Hagerty Inc.

N/A

Current Price

$13.43

Market Cap

1.1B

Sector

Finance

ML Signal

N/A

Logo Alpha Tau Medical Ltd.

DRTS

Alpha Tau Medical Ltd.

N/A

Current Price

$14.70

Market Cap

1.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HGTY
DRTS
Founded
1984
2015
Country
United States
Israel
Employees
N/A
N/A
Industry
Specialty Insurers
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.0B
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
HGTY
DRTS
Price
$13.43
$14.70
Analyst Decision
Buy
Strong Buy
Analyst Count
6
3
Target Price
$13.67
$8.67
AVG Volume (30 Days)
145.0K
492.6K
Earning Date
05-06-2026
05-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,456,389,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$17.74
$699.98
P/E Ratio
N/A
N/A
Revenue Growth
21.36
N/A
52 Week Low
$9.36
$3.18
52 Week High
$14.00
$15.02

Technical Indicators

Market Signals
Indicator
HGTY
DRTS
Relative Strength Index (RSI) 62.77 63.87
Support Level $13.08 $6.47
Resistance Level $13.94 $14.75
Average True Range (ATR) 0.41 0.61
MACD 0.01 0.06
Stochastic Oscillator 51.54 87.42

Price Performance

Historical Comparison
HGTY
DRTS

About HGTY Hagerty Inc.

Hagerty Inc is a provider of specialty automotive insurance. The company underwrites, sells, and services classic car and enthusiast vehicle insurance policies. Substantial revenue is derived from Commission and fees. Geographically, it serves Europe, Canada, and the United States.

About DRTS Alpha Tau Medical Ltd.

Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.

Share on Social Networks: